Why Is Eletriptan So Hard to Find? [Explained for 2026]

If you've been prescribed eletriptan (brand name Relpax) for migraines and recently hit a wall at the pharmacy — whether you were told it was out of stock, your insurance wouldn't cover it, or you simply couldn't get the quantity you needed — you're not alone. Patients across the country report frustration filling eletriptan prescriptions, even though the drug is not on the FDA's official shortage list.

So what's actually going on? The answer lies in a combination of insurance quantity limits, pharmacy stocking decisions, cost barriers, and the way triptans are covered on insurance formularies. This article breaks it all down.

Is Eletriptan in a Shortage in 2026?

As of 2026, eletriptan is NOT listed on the FDA's Drug Shortage Database. Generic eletriptan has been available since 2017, and multiple manufacturers supply the market. This is good news for availability overall — there is no manufacturing crisis causing a nationwide wipeout.

However, "not in a shortage" does not mean "easy to find." Patients routinely discover that one or more of the following barriers stands between them and their medication.

Why Do Patients Struggle to Find Eletriptan?

1. Insurance Quantity Limits Are Strict

This is the number one reason patients feel like they can't get enough eletriptan. Most insurance plans, including those administered by major carriers like Cigna, Aetna, and UnitedHealth, impose strict quantity limits on triptans — typically 4 to 9 tablets per month per prescription. For a patient who has 4 or more migraines a month, this can leave them rationing doses or running out well before their next refill window.

Generic sumatriptan (the cheapest and oldest triptan) often gets higher quantity limits — 9 tablets/month or more on most plans — while eletriptan, which tends to sit on a higher formulary tier, may be capped at just 4 to 6 tablets per month. That's potentially only 2 to 3 migraines' worth of treatment when dosed at 40 mg twice (the maximum recommended per migraine).

2. Prior Authorization and Step Therapy Requirements

Some insurance plans require step therapy before they will cover eletriptan — meaning you must first try and fail on a cheaper triptan (usually sumatriptan) before the plan will approve eletriptan. If your doctor prescribes eletriptan as a first-line treatment, your pharmacy may flag it for prior authorization, causing delays of days or even weeks.

If you've already tried sumatriptan and it didn't work (or caused intolerable side effects), your doctor can document that in a prior authorization request. Getting that documentation submitted quickly is key to unlocking coverage.

3. Pharmacy Stocking Gaps

Even without a formal shortage, individual pharmacies don't always stock every triptan in every strength. Large chain pharmacies use automated inventory systems based on local dispensing history. If a given location doesn't fill many eletriptan prescriptions, it may not keep consistent stock on hand — especially for the 20 mg strength, which is less commonly prescribed than the 40 mg tablet.

Independent pharmacies are often a better bet. They tend to have more flexibility to order specific medications and are more likely to accommodate requests for less common quantities or strengths.

4. The High Cash Price Without Insurance

Eletriptan's cash price without insurance or a discount card is shockingly high. The retail price for 6 tablets of generic eletriptan can run $300 to $420, and brand-name Relpax can cost over $500. For patients who are uninsured, underinsured, or whose insurance won't cover it, this price alone can make the medication effectively inaccessible.

The good news is that with a GoodRx or SingleCare coupon, generic eletriptan can be obtained for as low as $21 to $25 for 6 tablets — a reduction of 95% or more. Many patients don't realize these options exist or how much they can save.

5. Confusion Between Eletriptan and Relpax at the Pharmacy

Some patients run into problems when their prescription is written for one name and filled (or not filled) under another. Relpax is the brand name, eletriptan hydrobromide is the full generic name, and eletriptan is the common short name. Make sure your prescription is written for generic eletriptan — not brand-name Relpax — unless brand is specifically required. Insurance will almost always require the generic first, and the generic is where the savings are.

What Can You Do If You Can't Get Eletriptan Filled?

Here are practical steps you can take right now:

Use a discount card immediately. GoodRx and SingleCare coupons bring generic eletriptan down to $21–$25 for 6 tablets. You can use these instead of insurance — and they often save you more than your copay.

Try different pharmacies. If one chain doesn't have it in stock, an independent pharmacy or mail-order pharmacy may. Prices also vary significantly by pharmacy even with a coupon.

Ask your doctor for a higher quantity prescription. If insurance limits you to 4 tablets/month, you can fill additional tablets as a cash-pay prescription using a GoodRx coupon at the same visit.

Work with your doctor on a prior authorization. If your insurer requires step therapy, have your doctor document your history with other triptans to support the PA request.

Use medfinder. medfinder calls pharmacies near you to check which ones have eletriptan in stock, saving you from making dozens of calls yourself.

Is There a Long-Term Solution?

If you consistently struggle to get enough eletriptan to manage your migraines, it may be worth having a conversation with your neurologist or headache specialist about your overall migraine treatment plan. Preventive medications — such as CGRP monoclonal antibodies (like Aimovig or Emgality) or beta-blockers — can reduce the number of migraines you have each month, which means you need fewer acute treatments. You can also explore alternatives to eletriptan if insurance barriers become too burdensome.

And remember: no matter what pharmacy challenges you face, medfinder is here to help you find pharmacies that have your medication in stock. We call pharmacies so you don't have to.

The Bottom Line

Eletriptan is not in an FDA shortage — but insurance barriers, pharmacy stocking practices, and high cash prices create real-world access challenges for many patients. Understanding the system helps you navigate it more effectively. For the latest on eletriptan availability, see our 2026 eletriptan shortage update.